Agonistic antibodies directed at cell surface receptors and cardiovascular disease

Journal of the American Society of Hypertension

Volumn 2, Issue 1, 2008, Pages 8-14

  Luft, Friedrich C ^a   Dechend, Ralf ^a   Dragun, Duska ^a   Müller, Dominik N ^a   Wallukat, Gerd ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Adrenergic receptors; angiotensin; antibodies; AT1 receptor

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; AUTOANTIBODY; BETA ADRENERGIC RECEPTOR; CELL SURFACE RECEPTOR; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; REACTIVE OXYGEN METABOLITE; RECEPTOR ANTIBODY; RENIN;

ACUTE GRAFT REJECTION; ANTIBODY PRODUCTION; AUTOIMMUNITY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CONNECTIVE TISSUE DISEASE; DRUG RESEARCH; EVIDENCE BASED MEDICINE; FIBROBLAST; HUMAN; HYPERTENSION; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS;

EID: 38149133744     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.08.005     Document Type: Review

References (45)

1. Kim-Saijo M., Akamizu T., Ikuta K., Iida Y., Ohmori K., Matsubara K., et al. Generation of a transgenic animal model of hyperthyroid Graves' disease. Eur J Immunol 33 (2003) 2531-2538
2. Fareau G.G., Maldonado M., Oral E., and Balasubramanyam A. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome. Metabolism 56 (2007) 670-675
3. Takeda K., Stagg J., Yagita H., Okumura K., and Smyth M.J. Targeting death-inducing receptors in cancer therapy. Oncogene 26 (2007) 3745-3757
4. Bartholdy C., Kauffmann S.O., Christensen J.P., and Thomsen A.R. Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus. J Immunol 178 (2007) 1662-1670
5. Fu M.L., Wallukat G., Hjalmarson A., and Hoebeke J. Characterization of anti-peptide antibodies directed against an extracellular immunogenic epitope on the human alpha 1-adrenergic receptor. Clin Exp Immunol 97 (1994) 146-151
6. Fu M.L., Herlitz H., Wallukat G., Hilme E., Hedner T., Hoebeke J., et al. Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet 344 (1994) 1660-1663
7. Luther H.P., Homuth V., and Wallukat G. Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 29 (1997) 678-682
8. Wallukat G., and Wollenberger A. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biomed Biochim Acta 46 (1987) S634-S639
9. Magnusson Y., Wallukat G., Waagstein F., Hjalmarson A., and Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 89 (1994) 2760-2767
10. Wallukat G., Wollenberger A., Morwinski R., and Pitschner H.F. Anti-beta1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. [Erratum in: J Mol Cell Cardiol 1995;27:2529]. J Mol Cell Cardiol 27 (1995) 397-406
11. Ferrari I., Levin M.J., Wallukat G., Elies R., Lebesgue D., Chiale P., et al. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med 182 (1995) 59-65
12. Jahns R., Boivin V., Hein L., Triebel S., Angermann C.E., Ertl G., et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113 (2004) 1419-1429
13. Störk S., Boivin V., Horf R., Hein L., Lohse M.J., Angermann C.E., et al. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 152 (2006) 697-704
14. Staudt A., Staudt Y., Dorr M., Bohm M., Knebel F., Hummel A., et al. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 44 (2004) 829-836
15. Müller J., Wallukat G., Dandel M., Bieda H., Brandes K., Spiegelsberger S., et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101 (2000) 385-391
16. Podlowski S., Luther H.P., Morwinski R., Müller J., and Wallukat G. Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes. Circulation 98 (1998) 2470-2476
17. Staudt A., Hummel A., Ruppert J., Dorr M., Trimpert C., Birkenmeier K., et al. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 152 (2006) 712.e1-712.e6
18. Fu M.L., Schulze W., Wallukat G., Elies R., Eftekhari P., Hjalmarson A., et al. Immunohistochemical localization of angiotensin II receptors (AT1) in the heart with anti-peptide antibodies showing a positive chronotropic effect. Receptors Channels 6 (1998) 99-111
19. Fu M.L., Leung P.S., Wallukat G., Bergstrom G., Fu H., Schulze W., et al. Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide. Blood Press 8 (1999) 317-324
20. Wallukat G., Homuth V., Fischer T., Lindschau C., Horstkamp B., Jupner A., et al. Patients with pre-eclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103 (1999) 945-952
21. Fu M.L., Herlitz H., Schulze W., Wallukat G., Micke P., Eftekhari P., et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 18 (2000) 945-953
22. Dechend R., Viedt C., Müller D.N., Ugele B., Brandes R.P., Wallukat G., et al. AT1 receptor agonistic antibodies from pre-eclamptic patients stimulate NADPH oxidase. Circulation 107 (2003) 1632-1639
23. Bohlender J., Ganten D., and Luft F.C. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J Am Soc Nephrol 11 (2000) 2056-2061
24. Dechend R., Gratze P., Wallukat G., Shagdarsuren E., Plehm R., Brasen J.H., et al. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of pre-eclampsia. Hypertension 45 (2005) 742-746
25. Xia Y., Wen H., Bobst S., Day M.C., and Kellems R.E. Maternal autoantibodies from pre-eclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 10 (2003) 82-93
26. Thway T.M., Shlykov S.G., Day M.C., Sanborn B.M., Gilstrap III L.C., Xia Y., et al. Antibodies from pre-eclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation. Circulation 110 (2004) 1612-1619
27. Bobst S.M., Day M.C., Gilstrap III L.C., Xia Y., and Kellems R.E. Maternal autoantibodies from pre-eclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 18 (2005) 330-336
28. Zhou C.C., Ahmad S., Mi T., Xia L., Abbasi S., Hewett P.W., et al. Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res 100 (2007) 88-95
29. Hubel C.A., Wallukat G., Wolf M., Herse F., Rajakumar A., Roberts J.M., et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of pre-eclampsia. Hypertension 49 (2007) 612-617
30. Herse F., Dechend R., Harsem N.K., Wallukat G., Janke J., Qadri F., et al. Dysregulation of the circulating and tissue-based renin-angiotensin system in pre-eclampsia. Hypertension 49 (2007) 604-611
31. Walther T., Wallukat G., Jank A., Bartel S., Schultheiss H.P., Faber R., et al. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 46 (2005) 1275-1279
32. Stepan H., Faber R., Wessel N., Wallukat G., Schultheiss H.P., and Walther T. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab 91 (2006) 2424-2427
33. Stepan H., Wallukat G., Schultheiss H.P., Faber R., and Walther T. Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?. J Reprod Immunol 73 (2007) 130-134
34. Dragun D., Müller D.N., Brasen J.H., Fritsche L., Nieminen-Kelha M., Dechend R., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352 (2005) 558-569
35. Baroni S.S., Santillo M., Bevilacqua F., Luchetti M., Spadoni T., Mancini M., et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354 (2006) 2667-2676
36. Svegliati S., Olivieri A., Campelli N., Luchetti M., Poloni A., Trappolini S., et al. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 110 (2007) 237-241
37. Collins J., and Gough S. Autoimmunity in thyroid disease. Eur J Nucl Med Mol Imaging 29 Suppl 2 (2002) S417-S424
38. Venter J.C., and Fraser C.M. Beta-adrenergic receptor structure, synthesis, antibodies and human disease. Bull Eur Physiopathol Respir 21 (1985) 13S-18S
39. Schroeder C., Vernino S., Birkenfeld A.L., Tank J., Heusser K., Lipp A., et al. Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353 (2005) 1585-1590
40. Nikolaev V.O., Boivin V., Stork S., Angermann C.E., Ertl G., Lohse M.J., et al. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 50 (2007) 423-431
41. Pendergraft III W.F., Pressler B.M., Jennette J.C., Falk R.J., and Presont G.A. Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease. J Mol Med 83 (2005) 12-25
42. Widmer M., Villar J., Benigni A., Conde-Agudelo A., Karumanchi S.A., and Lindheimer M. Mapping the theories of pre-eclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 109 (2007) 168-180
43. Scornik J.C., Guerra G., Schold J.D., Srinivas T.R., Dragun D., and Meier-Kriesche H.U. Value of post-transplant antibody testing in the evaluation of patients with renal graft dysfunction. Am J Transplant 7 (2007) 1808-1814
44. Tachikawa K., and Briggs S.P. Targeting the human genome. Curr Opin Biotechnol 17 (2006) 659-665
45. Xia Y., Ramin S.M., and Kellems R.E. Potential roles of angiotensin receptor-activating antibody in the pathophysiology of pre-eclampsia. Hypertension 50 (2007) 269-275